New PHE Study Released on Cost of Nonadherence
A novel approach to measuring the cost of nonadherence is outlined in a new article by Precision experts Jason Shafrin, Ross Maclean, and colleagues. The authors report findings of an adherence-exposure-outcome model simulation on the impact of nonadherence on progression-free survival in Cancer Management and Research.
To read the complete article as it appears in the publication, please click here.
In this unique one-hour webinar, Dr. Jena outlines a broader framework for assessing value to improve identification of not only the highest-value treatments, but also low-value therapies on which spending can safely be reduced.